DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer

Dehai Wang,Zhongbo Li,Xin Li,Cheng Yan,Huijie Yang,Ting Zhuang,Xiao Wang,Yifeng Zang,Ziping Liu,Tianshi Wang,Rixia Jiang,Peng Su,Jian Zhu,Yinlu Ding
DOI: https://doi.org/10.1186/s13046-022-02410-5
2022-07-13
Abstract:The Hippo pathway functions as a tumor suppressor pathway in human cancers, while dysfunction of the Hippo pathway is frequently observed in malignancies. Although YAP/TAZ activity is tightly controlled by the phosphorylation cascade of the MST-LATS-YAP/TAZ axis, it is still unclear why the YAP/TAZ proteins are activated in human cancers despite Hippo pathway activation. Recent studies have suggested that in addition to phosphorylation, several other posttranslational modifications, including ubiquitination, also play critical roles in modulating TAZ function.
oncology
What problem does this paper attempt to address?